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Abstract  
Objective: To evaluate H. pylori infection and virulent strain in diabetic children.  
Patients: In this study 53 type 1 diabetics and 53 of normal volunteers were included.  
Methods: All studied children were subjected to assessment of glycosylated hemoglobin (HbA1), 
Anti H. pylori antibodies (IgA, IgG, IgM), Anti-cytotoxin associated gene A antibodies (Anti Cag A 
IgG).  
Results: Anti H. pylori antibodies IgA, IgG, total antibodies and anti Cag A IgG were significantly 
higher in diabetics. Diabetic patients with positive anti Cag A IgG had a lower age of onset of 
diabetes, higher age of patients, body mass index (BMI) and HbA1.  
Conclusion: High prevalence of infection with the virulent strain of H. pylori among diabetic 
children with older age, large BMI, high HbA1 and younger age of onset of disease. The screening 
for the virulent strain in diabetic patients with poor metabolic control is mandatory. Control of 
diabetes is essential to present the infection with H. pylori. 
 
  
 
 
 
 
Introduction 
The relationship between diabetes mellitus 
(DM) and Helicobacter pylori (H. pylori) infection is 
controversial. According to some studies there is a 
high prevalence of H. pylori infection in patients with 
either type 1 [1] or type 2 DM [2]. 
An impaired immune response in diabetes 
that alters both humoral and cellular immunity, and the 
high prevalence of upper gastrointestinal symptoms, 
have led to speculation that H. pylori may be linked to 
diabetes [3]. This could be related to a reduced gastric 
motility and peristaltic activity, various chemical 
changes in gastric mucosa following non-enzymatic 
glycosylation processes [4] and an impaired non-
specific immunity observed in diabetic patients [5]. 
 We are aiming to evaluate H. pylori infection 
and virulent strain in diabetic children. Also to detect 
its relation to (gastrointestinal tract) G.I.T symptoms 
and glycemic control. 
Patients and Methods 
It is a cross sectional study, performed after 
obtaining approval by the ethical committee of the 
national Research Centre. Written informed consent 
was obtained from all patients and their parents after 
full discussion about the aim of the study.  
The study included 53 patients with type 1 DM 
among those attending to the endocrine clinic National 
Research Center. The control group consisted of 53 
age and sex matched healthy normal volunteers. 
 
Exclusion criteria  
 - Children with other types of diabetes.  
 - Diabetic children with other chronic disease. 
 - Children on or used medical treatment for 
eradication of H. pylori within the last two months. 
Methods  
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 All studied children were subjected to 
complete history taking with special emphasis on GIT 
symptoms. 
 
Anthropometric measurements 
Anthropometric measurements in the form of 
weight, height were taken for each participant. The 
weight and height of the participants were measured 
up to 0.01 kg and 0.1 cm using a Seca Scale Standing 
Balance and a Harpenden Stadiometer (Holtain, Ltd, 
Crymmych, Wales, U.K.). Body mass index (BMI) was 
calculated as weight (in kilograms) divided by height 
(in meters) squared.  
Table 1: Comparison between Demographic data of diabetic 
patients and controls. 
Variables Patients Controls P-value 
Sex:    
Males  N (%) 24 (45.3 ) 28 (52.8) 0.4 
Females N (%) 29 (54.7) 25 (47.2)  
Age (yrs)  
Mean ± SD 
12.2  ± 3.0 12.5 ± 3.5 0.8 
BMI (kg/m
2
) 
Mean ± SD 
21.86 ± 5.06 18.15 ± 2.77 0.0001 
HbA1 (%) 
Mean ± SD 
9.6 ± 1.6 5.4 ± 0.7 0.0001 
Chi Square test [N (%)]; Mann Whitney U test for independent variables :  Mean ± SD; 
BMI: body mass index. 
 
 Laboratory investigation 
 Glycosylated hemoglobin (HbA1) was done 
every 3 months and the mean value was calculated 
per year. It was measured using high pressure liquid 
chromatography (Nichols Institute, Van Nuys, 
California). 
 Anti H. pylori antibodies (IgA): Using 
quantitative enzyme immuranssay kit. The test kit was 
suppliedcalbitech, catalog No, HPO14A, USA [6].  
Anti H. Pylori antibodies (IgM) using 
quantitative enzyme immunoassay kit. The test kit 
was supplied by calbiotech catalog No. Hp015M, USA 
[7]. ELISA sensitivity and specificity were 90%, and 
the predictive value of negative result is high.  
Anti H. Pylori antibodies (IgG) using enzyme 
immunoassay for quantitative and qualitative 
determination of anti H. pylori IgG in human serum or 
plasma. The test kit was supplied by Diakey catalog 
No, DE101 USA [8]. 
Anti-cytotoxin associated gene A antibodies 
(Anti Cag A IgG): It's an ELISA for the quantitative 
determination of anti Cag A IgG antibodies in human 
serum or plasma for in vitro diagnostic use only. The 
kit was supplied by ELISA, catalog No 4138, USA [9]. 
 
Statistical Analysis 
Statistical analysis was conducted using 
Statistical Package for Social Science (SPSS) 
program version 15.0 (Chicago, Illinois, USA). Mann 
Whitney U test for independent variables was done as 
data was not symmetrically distributed. Chi- Square 
test was used for qualitative data.  
 
Results 
The study included 53 type 1 diabetic patients 
(24 males and 29 females), their mean age was 12.2 
± 3.0, mean duration of diabetes was 4.5 ± 3.3, mean 
insulin dose/kg was 1.4 ± 0.5, mean BMI was 21.86 ± 
5.06 and mean HbA1 was 9.6 ± 1.6. Comparison 
between sex, age, BMI, HbA1 of diabetics and 
controls was shown in Table 1.  
Table 2: Comparison between H. pylori antibody (IgA, IgG and 
IgM) and Anti Cag A IgG of patients and controls.  
Variables 
Diabetics Controls 
P-value 
No. % No. % 
Anti H. Pylori IgA:      
Positive 6 11.3 0 0 0.012 
Negative 47 88.7 53 100  
Anti H. Pylori IgM:     
0.558 Positive 2 3.7 1 1.8 
Negative 51 92.4 52 98.2 
Anti H. Pylori IgG:     
0.006 Positive 38 71.7 24 45.28 
Negative 15 28.3 29 54.72 
Total antibodies :      
Positive 40 75.5 13 24.5 0.001 
Negative 25 47.2 28 52.8  
Anti Cag A  IgG:      
Positive 30 56.6 0 0 0.0001 
Negative 23 43.4 53 100  
Chi Square test; Positive total antibodies: either IgA or IgM or IgG is positive; Negative 
total antibodies: all antibodies ( IgA, IgM and IgG) are negative. 
 
Anti H. Pylori (IgA, IgG and total antibodies) 
and Anti Cag A IgG were significantly higher in 
diabetics than controls (Table 2).  
Table 3: Comparison between demographic data, HbA1 and 
clinical data regarding total antibodies in diabetics 
Variables 
Negative  total  
antibodies 
Positive total 
 antibodies 
P-value 
Sex:    
Males N (%) 5 (38.5) 19 (47.5) 0.3 
Females N (%) 8 (61.5) 21 (52.5)  
Age (yrs) 
Median 
Mean ± SD 
Range 
 
12.0 
11.8 ± 3.2 
5 -16 
 
13.0 
12.5 ± 3.5 
4-17 
 
0.4 
Duration of disease (yrs) 
Median 
Mean ± SD 
Range 
 
6.0 
5.6 ± 3.3 
2 -12 
 
3 
4.2 ± 3.2 
1 -11 
 
 
0.1 
Age of onset of disease 
(yrs) 
Median 
Mean ± SD 
Range 
 
6.0 
6.2 ± 3.7 
1 -12 
 
8.0 
8.4 ± 4.2 
1 -15.5 
 
0.08 
Insulin dose (U/kg) 
Median 
Mean ± SD 
Range 
 
1.4 
1.4 ± 0.3 
0.8 – 2.2 
 
1.4 
1.5 ± 0.6 
0.6 – 3.4 
 
0.8 
BMI (kg / m2) 
Median 
Mean ± SD 
Range 
 
21.6 
22.1 ± 5.3 
12 – 30 
 
21.6 
21.8 ± 5.0 
13 – 34 
 
0.7 
HbA1 (%) 
Median 
Mean ± SD 
Range 
 
8.0 
7.9 ± 1.3 
4.5 – 10.1 
 
7.5 
7.4 ± 1.6 
3.0 – 10.6 
 
0.1 
Clinical data:    
Epigastric pain:    
Negative  N (%) 1 (6.7) 7 (18.4) 0.3 
Positive N (%) 14 (93.3) 31 (81.6)  
Recurrent  abdominal  
pain: 
   
Negative N (%) 6 (40) 22 (57.9) 0.2 
Positive N (%) 9 (60) 16 (42.1)  
Nausea & vomiting:    
Negative N (%) 5 (33.3)  18 (47.4) 0.3 
Positive N (%) 10 (66.7) 20 (52.6)  
Abdominal distension:    
Negative N (%) 10 (66.7) 16 (42.1) 0.1 
Positive N (%) 5 (33.3) 22 (57.9)  
Mann  Whitney  U  test (median/mean ± SD) range;   Chi Square test [N (%)];    BMI: body 
mass index; HbA1: Glycosylated hemoglobin;  Positive total antibodies: either  IgA or IgM 
or IgG is positive;  Negative total antibodies: all antibodies (IgA, IgM and IgG) are 
negative. 
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Comparison between demographic data, 
HbA1 and clinical data regarding total antibodies and 
anti Cag A IgG antibody in diabetics is shown in 
Tables 3 and 4.  
Table 4: Comparison between demographic data, HbA1 and 
clinical data regarding  Anti Cag A IgG. 
Variables Negative 
 anti Cag A IgG 
antibodies 
Positive  
anti Cag A IgG 
  antibodies 
P-value 
Sex:    
Males N (%) 7 (30.4) 17 (56.7) 0.07 
Females N (%) 16 (69.6) 13 (43.3)  
Age (yrs) 
Median 
Mean ± SD 
Range 
 
12.0 
11.2 ± 3.8 
3.5 – 16.0 
 
13.0 
12.9 ± 1.9 
8.0 – 17.0 
 
0.04 
Duration of disease 
(yrs) 
Median 
Mean ± SD 
Range 
 
3.0 
3.8 ± 2.4 
2.0 – 10.0 
 
4.0 
5.2 ± 3.7 
1.0 – 12.0 
 
0.4 
Age of onset of 
disease (yrs) 
Median 
Mean ± SD 
Range 
 
9.0 
4.6 ± 3.2 
1.0 – 15.5 
 
7.0 
6.4 ± 2.8 
1.0 – 15.0 
 
0.03 
Insulin dose (U/kg) 
Median 
Mean ± SD 
Range 
 
1.4 
1.4 ± 0.2 
0.8 – 1.8 
 
1.4 
1.5 ± 0.7 
0.6 – 3.4 
 
0.8 
BMI (kg / m2) 
Median 
Mean ± SD 
Range 
 
19.5 
19.7 ± 3.7 
12.0 – 28.0 
 
23.3 
23.5 ± 5.4 
13.0 – 34.0 
0.007 
HbA1 (%) 
Median 
Mean ± SD 
Range 
 
7.4 
7.1 ± 1.5 
3.0 – 10.2 
 
8.0 
8.1 ± 1.4 
5.0 – 10.6 
 
0.03 
Clinical data:    
Epigastric pain:    
Negative N (%) 5 (21.7) 3 (10) 0.2 
Positive N (%) 18 (78.3) 27 (90)  
Recurrent abdominal 
pain: 
   
Negative N (%) 11 (47.8) 17 (56.7) 0.4 
Positive N (%) 12 (52.2) 13 (43.3)  
Nausea & vomiting:    
Negative N (%) 9 (39.1) 14 (46.7) 0.4 
Positive N (%) 14 ( 60.9) 16 (53.3)  
Abdominal 
distension: 
   
Negative N (%) 13 (56.5) 13 (43.3) 0.3 
Positive N (%) 10 (43.5) 17 (56.7)  
Mann Whitney U test (median/ mean ± SD/range);   Chi Square test [N (%)];    BMI: body 
mass index; HbA1: Glycosylated hemoglobin;  Positive total antibodies: either IgA or IgM 
or IgG is positive;  Negative total antibodies: all antibodies (IgA, IgM and IgG) are 
negative. 
 
Discussion 
The role of gender as a risk factor for H. pylori 
infection is still debated. The present study showed 
that there was no significant difference in the 
prevalence of infection between boys and girls 
regarding total antibodies or infection with virulent 
strain of H. pylori (anti Cag A Ig G positive) in the 
diabetics. This result comes in agreement with 
Mahmoud et al. [10], who revealed that no gender 
difference in H. pylori infection was found. On the 
other hand, another study confirmed the male 
predominance of H. pylori infection [11], while the 
study of Kanbay et al. [12] stated that H. pylori 
infected females were predominant as compared to 
males. 
Our study confirmed the previously described 
increased prevalence of H. pylori infection with age 
(13-16), as it was detected by increased total 
antibodies (either IgA or IgM or IgG is positive) in 
diabetic group, but this increase was not statistically 
significant. This age is related to increase in the 
seroprevalence of H. pylori infection may be due to 
progressive acquisition of infection by the increase of 
age [17], and changes in the environmental factors 
[18]. Our study revealed that body mass index (BMI) 
was a statistically significant higher in diabetics and is 
related to the presence of insulin resistance [19]. 
The present study revealed that the 
prevalence of H. pylori infection regarding total anti-H. 
pylori antibodies was significantly higher in the 
diabetic group (75.5%). These coincide with the result 
of Mohammed and Abdel-Kareem [20], who reported 
that the prevalence was 74%. On the other hand, it 
was higher than that reported by Salardi et al. [21] and 
Arslan et al. [1] (48.5 % and 55.6 % respectively). It is 
related to the higher prevalence of H. pylori infection 
in the developing than developed countries. 
The relation between type 1 DM and H. pylori 
infection is still controversial. According to some 
studies, there is a high prevalence of H. pylori 
infection in patients with either type1 DM [1], or type 2 
DM [2], which is correlated with the duration of DM, 
age of diabetic patients [21], the presence of 
dyspeptic symptoms [2], gender, BMI, blood pressure, 
fasting blood sugar and HbA1 [22]. This could be 
related to a reduced gastric motility and peristaltic 
activity [23], various chemical changes in the gastric 
mucosa following non-enzymatic glycosylation 
processes of mucus and increased sialic acid 
production which acts as a receptor for H. pylori on 
the cell surface by promoting adhesion of H. pylori to 
gastric mucosa cells [24]. However, there is limited 
data regarding the influence of H. pylori infection on 
the clinical course of diabetes, with controversial 
results [25]. 
  In the current study, the prevalence of 
infection with the virulent strain of H. pylori (anti Cag A 
IgG) in the diabetic group was (56.6%). This result 
was higher than that detected by Fayed et al. [16] who 
reported that the prevalence of infection by virulent 
strain of H. pylori was (35%) in a group of children 
with GIT complaints and not diabetic. 
The present study revealed that there was no 
significant difference in GIT symptoms regarding total 
anti H. pylori antibodies and anti Cag A IgG in 
diabetics. On the other hand, Leo et al. [26], reported 
that epigastric pain was predominant in H. pylori 
infected children. Fayed et al. [16] found that the most 
commonly recorded GI symptoms were anorexia and 
diarrhea (50% each), recurrent abdominal pain (RAP) 
(41.7%) and recurrent vomiting (16.7%) but those 
patients were non diabetic. Fayed et al. [27], found 
that the most commonly recorded (gastrointestinal) GI 
symptoms, in association with H. pylori infection were 
anorexia and diarrhea (40% each), RAP (41.79%), 
heart burn (33.3%), dyspepsia (25%), vomiting 
(16.7%) and abdominal distension (8.3%). This 
contradiction regarding the relation between H. pylori 
Fayed et al. Helicobacter Pylori Infection in Children with Type 1 Diabetes Mellitus 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
OA Maced J Med Sci. 2014 Mar 15; 2(1):114-118.                                                                                                                                                                         117 
 
infection and GIT symptoms in different studies may 
be due to the different studied samples and the 
infection with different pathogenic strains of H. pylori. 
Supporting this hypothesis is the increased frequency 
of RAP among children infected by toxin producing 
strains (virulent strains) when compared to children 
infected by non virulent strains [16]. The other factors 
that influence the variability of symptoms arising are 
the genetic constitution, the age of the host, the 
duration of illness and the environmental factors [28]. 
As regard infection by the virulent strain of H. 
pylori, our study reported that the prevalence of 
infection by the virulent strain in the diabetic group 
was 56.6%, while no one was infected by the virulent 
strain of H. pylori in the control group and this can 
explain the absence of GIT symptoms in the control 
group, although (24.5%) of them were infected by 
non-virulent strain of H. pylori (positive total 
antibodies).  
In the current study, we found that diabetic 
patients infected with the virulent strain of H. pylori 
(Anti Cag A IgG) were older than those who are anti 
Cag A negative. This result comes in agreement with 
Fayed et al. [16]. This might be due to more exposure 
of the population to the organism with increasing the 
age.  
Our study revealed that the duration of 
diabetes is longer in diabetic group as regard anti Cag 
A IgG, but it was not statistically significant (P>0.05). 
This result comes in agreement with Mohammed and 
Abdel-Kareem [20], Gasbarrini et al., [29]; Saladi et 
al., [21] and Arslan [1], who found that the duration of 
diabetes was the only factor affecting H. pylori status 
in these patients. However, other investigators did not 
find any association between H. pylori infection and 
the duration of diabetes mellitus [4, 30]. 
The present study revealed that infection with 
H. pylori regarding total antibodies was not associated 
with poor glycemic control in the diabetic group (i.e., 
no significant change in the level of HbA1) (P>0.05). 
This result comes in agreement with Ojetti et al. [31]. 
In contrast, Dore et al. [32], reported that infection with 
H. pylori was associated with poor glycemic control of 
diabetics. 
On the other hand, we found that diabetics 
with virulent strain of H. pylori (Anti-Cag A IgG) had a 
significant higher level of HbA1. This result was in 
agreement with Rodolfo et al. [33]. One possible 
explanation of that finding was that metabolic 
derangements that occur in diabetes may impair a 
number of host defenses in both humoral and cellular 
immunity (neutrophil dysfunction, chemotaxis failure 
and decreased lymphocyte activity) It has been 
speculated that alterations in the glucose metabolism 
may promote H. pylori colonization [23]. BMI was 
significantly higher in our diabetics with positive Anti 
Cag A IgG. This can be explained that, uncontrolled 
diabetic patients usually had increase in insulin 
resistance and it lead to increase in BMI of diabetics. 
On the present study, total daily insulin 
dosage/kg had no significant relation to infection with 
H. pylori (total antibodies) or the virulent strain of H. 
pylori. On the contrary, Begue et al. [34], reported that 
children with type 1 diabetes and H. pylori infection 
had an increased daily insulin requirement compared 
with the requirement of their uninfected peers. 
We conclude that, diabetic children are more 
vulnerable to infection by H. pylori virulent strain as it 
was detected by anti Cag A IgG. Also, the infection by 
virulent strain is associated with older age of patients, 
larger BMI, Higher HbA1 and lower age of onset of 
diabetes. We recommend screening for the virulent 
strain in patients with poor metabolic control of 
diabetes. Further large scale studies that address the 
role of H. pylori infection in the pathogenesis of 
diabetes mellitus are needed, as well as searching for 
a hopeful vaccine to prevent the so widely prevalent 
organism and to avoid the dangerous complications.  
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